BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5018741)

  • 1. Development of procoagulant (tissue thromboplastin) activity in cultured leukocytes.
    Kociba GJ; Loeb WF; Wall RL
    J Lab Clin Med; 1972 May; 79(5):778-87. PubMed ID: 5018741
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the coagulation factors from V through XIII].
    Yoshida K; Tagawa N
    Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
    [No Abstract]   [Full Text] [Related]  

  • 3. The procoagulant activity of granulocytes.
    Saba HI; Herion JC; Walker RI; Roberts HR
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
    [No Abstract]   [Full Text] [Related]  

  • 4. Cofactor of the "lupus anticoagulant".
    Rivard GE; Schiffman S; Rapaport SI
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):554-63. PubMed ID: 4141516
    [No Abstract]   [Full Text] [Related]  

  • 5. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    Pineo GF; Regoeczi E; Hatton MW; Brain MC
    J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
    BaƄkowski E; Worowski K
    Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of human leukocyte thromboplastic activity by endotoxin.
    Lerner RG; Goldstein R; Cummings G; Lange K
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):145-8. PubMed ID: 4942184
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation activity of surface activated plasma in vivo.
    Swedenborg J; Kourias E; Olsson P
    Thromb Res; 1979; 16(1-2):231-7. PubMed ID: 505418
    [No Abstract]   [Full Text] [Related]  

  • 9. Prothrombin utilization in congenital coagulation deficiency states.
    Owen CA; Thompson JH
    Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 11. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate.
    Vinazzer H
    Thromb Res; 1979 Jan; 14(1):155-66. PubMed ID: 425078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental models of human congenital coagulation defects].
    Kase F
    Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):41-4. PubMed ID: 7033960
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy.
    Zacharski LR; Rosenstein R
    Blood; 1979 Mar; 53(3):366-74. PubMed ID: 760859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion support for congenital clotting deficiencies other than haemophilia.
    Lewis JH; Spero JA; Ragni MV; Bontempo FA
    Clin Haematol; 1984 Feb; 13(1):119-35. PubMed ID: 6609789
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced tissue factor (thromboplastin) activity in von Willebrand's disease.
    Zacharski LR; Rosenstein R; Cornwell GG; Davis WM; McIntyre OR
    Am J Med; 1974 Jul; 57(1):102-7. PubMed ID: 4546024
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemostasis in kala-azar.
    Basu AK; Chatterjea JB; Sen Gupta PC; Mukherjee AM
    Trans R Soc Trop Med Hyg; 1970; 64(4):581-7. PubMed ID: 5485617
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary characterization of the procoagulant material in human ascites.
    Addonizio VP; Fisher CA; Strauss JF; Ewan VA; Rickles FR; Rosato EF; Harken AH; Inouye WY
    Surgery; 1987 Jun; 101(6):753-62. PubMed ID: 3589968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of tissue factor-based procoagulant activity (PCA) in pigeon monocyte-derived macrophages.
    Gupta M; Doellgast GJ; Cheng T; Lewis JC
    Thromb Haemost; 1993 Dec; 70(6):963-9. PubMed ID: 8165619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine plasma thromboplastin antecedent (Factor XI) deficiency.
    Kociba GJ; Ratnoff OD; Loeb WF; Wall RL; Heider LE
    J Lab Clin Med; 1969 Jul; 74(1):37-41. PubMed ID: 5256172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.